TAILOR-PCI Proves Genotype-guided Antiplatelet Therapy Reduces MACE
September 10th, 2020
TAILOR-PCI was a 7-year 5,300-patient clinical trial of precision medicine for cardiac stent patients, funded by Mayo Clinic and the National Institutes of Health (NIH). Spartan's FDA-cleared rapid RX CYP2C19 genotyping test was used to personalize antipl...
